HeartCore Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
HeartCore (Nasdaq: HTCR) received a 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price under Nasdaq Listing Rule 5550(a)(2).
The extension gives the company until May 1, 2026 to achieve a closing bid of at least $1.00 for 10 consecutive business days. The notice does not affect the current listing status of HTCR common stock. The company cautioned there is no assurance it will regain compliance even if other listing requirements are met.
HeartCore (Nasdaq: HTCR) ha ottenuto una estensione di 180 giorni da Nasdaq per ristabilire la conformità al prezzo minimo di offerta di $1.00 secondo la Nasdaq Listing Rule 5550(a)(2).
L'estensione concede all'azienda fino al 1 maggio 2026 per raggiungere un prezzo di chiusura di almeno $1.00 per 10 giorni lavorativi consecutivi. La nota non influisce sullo stato attuale dell'elenco delle azioni ordinarie HTCR. L'azienda avverte che non vi è alcuna garanzia che ripristinerà la conformità anche se saranno soddisfatti gli altri requisiti di quotazione.
HeartCore (Nasdaq: HTCR) recibió una prórroga de 180 días de Nasdaq para volver a cumplir con el precio mínimo de oferta de $1.00 bajo la Regla de listado 5550(a)(2) de Nasdaq.
La prórroga otorga a la empresa hasta el 1 de mayo de 2026 para lograr una oferta de cierre de al menos $1.00 durante 10 días hábiles consecutivos. El aviso no afecta el estado actual de la cotización de las acciones comunes de HTCR. La empresa advirtió que no hay garantía de que vuelva a cumplir incluso si se cumplen otros requisitos de listado.
HeartCore(Nasdaq: HTCR)는 Nasdaq로부터 180일 연장을 받아 $1.00 최소 매수가격를 Nasdaq 상장 규칙 5550(a)(2)에 따라 재준수한다.
연장 기간은 회사가 2026년 5월 1일까지 연속적으로 10영업일 이상 종가가 $1.00 이상으로 유지되도록 한다. 이 공지는 HTCR 일반주식의 현재 상장 상태에 영향을 미치지 않는다. 회사는 다른 상장 요건이 충족되더라도 재준수 여부에 대한 보장이 없다고 경고했다.
HeartCore (Nasdaq : HTCR) a obtenu une extension de 180 jours de la part de Nasdaq pour reprendre la conformité au prix d'offre minimum de 1,00 $ selon la règle de cotation Nasdaq 5550(a)(2).
L'extension accorde à l'entreprise jusqu'au 1er mai 2026 pour atteindre une offre de clôture d'au moins 1,00 $ pendant 10 jours ouvrables consécutifs. L'avis n'affecte pas l'état actuel de la cotation des actions ordinaires HTCR. L'entreprise avertit qu'il n'y a aucune garantie de reprendre la conformité même si les autres critères de cotation sont respectés.
HeartCore (Nasdaq: HTCR) erhielt von Nasdaq eine 180-tägige Verlängerung, um die Einhaltung des $1,00 Mindestkurs gemäß der Nasdaq Listing Rule 5550(a)(2) wiederherzustellen.
Die Verlängerung erlaubt dem Unternehmen, bis zum 1. Mai 2026 einen Schlusskurs von mindestens $1,00 für 10 aufeinanderfolgende Handelstage zu erreichen. Die Mitteilung hat keinen Einfluss auf den aktuellen Börsenlisting-Status von HTCR-Stammaktien. Das Unternehmen warnte, dass es keine Gewissheit gibt, die Einhaltung wiederherzustellen, selbst wenn andere Listing-Anforderungen erfüllt werden.
HeartCore (نيسداك: HTCR) تلقّت تمديداً لمدة 180 يوماً من Nasdaq لاستعادة الامتثال لـ سعر العرض الأدنى البالغ 1.00 دولار وفقاً لقواعد إدراج Nasdaq 5550(a)(2).
يعطي التمديد الشركة حتى 1 مايو 2026 لتحقيق سعر إغلاق لا يقل عن 1.00 دولار لمدة 10 أيام عمل متتالية. لا تؤثر النشرة على الوضع الحالي لإدراج HTCR العادي. حذّرت الشركة من أنه لا يوجد ضمان لاستعادة الامتثال حتى لو استوفت باقي متطلبات الإدراج.
- Nasdaq granted a 180-day extension to regain compliance
- Listing remains active during the extension period
- Must reach $1.00 closing bid for 10 consecutive business days
- No assurance the company will regain Nasdaq compliance by May 1, 2026
NEW YORK and TOKYO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, announced it has received an additional 180-day extension period from the Nasdaq Listing Qualifications Department (the “Nasdaq Staff”) to regain compliance with the
The extension notice has no immediate effect on the continued listing status of HeartCore’s common stock on The Nasdaq Capital Market under the symbol “HTCR.” The Company has until May 1, 2026, to meet the Minimum Bid Price Requirement. If at any time during the additional 180-calendar-day extension, the closing bid price of the common stock is at least
There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement, even if it maintains compliance with the other listing requirements.
About HeartCore Enterprises, Inc.
HeartCore is a Tokyo-based IPO consulting services company, guiding Japanese growth companies to achieve successful U.S. exchange listings through its flagship service, Go IPO. HeartCore’s Go IPOSM consulting services provide comprehensive consultation support, including pre-IPO consulting, regulatory guidance, financial preparation, and operational readiness to help businesses navigate the complexities of a successful U.S. listing. HeartCore’s goal is to streamline the entire process for Japanese companies to provide a seamless transition into the U.S. public markets. For more details, visit https://heartcore-enterprises.com/.
Forward-Looking Statements
All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.
HeartCore Investor Relations Contact:
Gateway Group, Inc.
John Yi and Steven Shinmachi
HTCR@gateway-grp.com
(949) 574-3860
FAQ
What did HeartCore (HTCR) announce on November 10, 2025 about Nasdaq compliance?
How long does HeartCore (HTCR) have to regain Nasdaq compliance and what is the deadline?
What specific Nasdaq rule does HeartCore (HTCR) need to comply with?
What condition will confirm HeartCore (HTCR) has regained compliance during the extension?
Does the Nasdaq extension affect HeartCore (HTCR)’s current listing status?
